Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
Blokirali ste korisnika/cu @Datamonitor_MR
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Datamonitor_MR
-
Michael Ramirez, Ph.D. proslijedio/la je Tweet
$GILD CAR-T Yescarta sales flattening out.https://twitter.com/bradloncar/status/1224803781340209153 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
First episode of the year for the Informa Pharma Intelligence Podcast, covering
#JPM20. Listen in as@Jessicaemerrill and@awmcconaghie share their key takeaways from the meeting:https://soundcloud.com/dmhcap/post-jpm-2020-podcast …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Michael Ramirez, Ph.D. proslijedio/la je Tweet
What a week it’s been - and it’s only Thursday! Here’s our (free)
#JPM20 Day 3 roundup. One more Notebook to come & many stories to follow over the coming weeks from insightful interviews@PharmaScrip &@PharmaPinkSheet did on the ground in San Francisco.https://scrip.pharmaintelligence.informa.com/SC141479/JP-Morgan-Notebook-Day-3-Skyrizi-Momentum-Builds-Whats-Next-For-Amarin-Viatris-Debuts-And-More …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Michael Ramirez, Ph.D. proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
For all those heading out to
#ASH19 this year, check out the Informa Pharma Intelligence Podcast (free) where we preview some abstracts that caught our eye!https://soundcloud.com/dmhcap/12032019-pre-ash-podcast …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
New Informa Pharma Intelligence Podcast episode: https://soundcloud.com/dmhcap/11012019-aducanumab-cell-and-gene-therapy-podcast …
@Datamonitor_PS Pamela Spicer talks aducanumab moving from futility to FDA filing for Alzheimer's disease@amandamicklus Amanda Micklus does a cell/gene therapy news round-up#aducanumab#genetherapyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
With
#ESMO19 wrapping up earlier this week, we sat down and discussed some of the presentations that we found interesting on the Informa Pharma Intelligence Podcast. Listen to our analysts' takeaways here:https://soundcloud.com/dmhcap/post-esmo-podcast …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Just wrapped another episode of the Informa Pharma Intelligence Podcast, this time on NASH and the TMB biomarker: https://soundcloud.com/dmhcap/083019-tmb-and-nash-podcast … Round out your workweek with a listen!
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Very interesting discussion on
#drugprices and proposals under the#Trump administration on the Informa Pharma Intelligence Podcast https://soundcloud.com/dmhcap/trump-pharma-pricing-policy-podcast … We discuss the Senate Finance Committee proposal, the rebate rule, and International Pricing IndexHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
With
#ASCO2019 now in the rear view mirror, we discuss some last thoughts on this year's conference on the completely free Informa Pharma Intelligence Podcast. Check it out!https://soundcloud.com/dmhcap/post-asco-podcast …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Michael Ramirez, Ph.D. proslijedio/la je Tweet
Check one off the list! Congratulations
@Amgen@ASCO https://twitter.com/BayAreaBiotechI/status/1135539157567266821 …pic.twitter.com/F8h9cINwx0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Michael Ramirez, Ph.D. proslijedio/la je Tweet
Publisher’s ASCO Spotlight: Compare Your Insights To Oncologists http://bit.ly/2Wz51Vz
#PharmaScripHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Check out our pre-
#ASCO2019 podcast, available for free! David Dahan@BMT_David1, Zachary McLellan@Datamonitor_ZM and I talk about presentations we're looking forward to https://soundcloud.com/dmhcap/05242019-pre-asco-podcast …$AZN$FTSV$LLY$ALPMY$SGEN$AMGN$NVS$MRKHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Years after being founded by renowned scientist Steven McKnight from UT Southwestern,
$MRK will now acquire Peloton Therapeutics for $1.05bn. Congrats, and looking forward to the Phase III for PT2977!https://www.cnbc.com/2019/05/21/merck-buys-peloton-therapeutics-to-expand-its-kidney-cancer-treatment-portfolio.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We will also be releasing a pre-
#ASCO2019 podcast Friday of next week!Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks to Dominique Fontanilla
@Datamonitor_DF, Laurie Withington@citelineLaurieW, Stephanie Yip@Datamonitor_SY and Pammy Spicer@Datamonitor_PS for joining the podcast!https://twitter.com/Datamonitor_MR/status/1129465054741426177 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Michael Ramirez, Ph.D. proslijedio/la je Tweet
Welcome to our
#AskTheAnalyst twitter chat! Our analysts are ready and waiting to answer your questions! Looking forward to seeing what you all ask!pic.twitter.com/dwrj8K1880Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
New episode of the completely free Informa Pharma Intelligence Podcast now live! - Failure of aducanumab - Preview of Meddevicetracker report on device regulatory timing - Recent results for Ocaliva in non-alcoholic steatohepatitis https://soundcloud.com/dmhcap/04192019a …
$BIIB$ESALY$ICPTHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Full comment on BioMedTracker can be found here: https://www.biomedtracker.com/EventDetail.cfm?EventID=338369 …https://twitter.com/Datamonitor_MR/status/1116460138536157185 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.